Marksans Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

19 Sep 2018 | 04:01 PM

35.00
-1.15 (-3.18%)

  • Underperforms Index

    -19.63%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 35.25%

  • More Volatile

    3.25%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.19%

  • Inconsistent Performer

    3/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

52

52.25

24

23.55

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Marksans Pharma Ltd has increased by 35.76% since past 3 Months

  • FII shareholding in Marksans Pharma Ltd has decreased by -49.7% since past 1 Year

Loading...